These results raise questions, therefore, about the value of these drugs as protective agents in the treatment of patients with ARVC. ARVC is an inherited disorder characterized by formation of ...

Background Regular intensive physical activity is associated with non-pathological changes in cardiac morphology. Differential diagnosis with arrhythmogenic right ventricular cardiomyopathy (ARVC) ...

The initiation of the RIDGE-1 Phase 1 trial with TN-401, aimed at treating arrhythmogenic right ventricular cardiomyopathy (ARVC), marks a significant milestone for the company. The therapy ...

The initiation of the Phase 1b RIDGE-1 clinical trial, which involves dosing the first patient with TN-401 for PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC), marks a ...